Liver transplantation is currently the only effective treatment for patients with end-stage liver
disease; however, donor liver scarcity is a notable concern. As a result, extensive endeavors …

The burden of liver diseases continues to grow worldwide, and liver transplantation is the
only option for patients with end‐stage liver disease. This procedure is limited by critical …

Liver transplantation from deceased or living human donors remains the only proven option
for patients with end-stage liver disease. However, the shortage of donor organs is a …

The definitive treatment for patients with end-stage liver disease is orthotropic
transplantation. However, this option is limited by the disparity between the number of …

Allogeneic liver transplantation is still deemed the gold standard solution for end-stage
organ failure; however, donor organ shortages have led to extended waiting lists for organ …

Severe liver diseases have been considered the most common causes of adult deaths
worldwide. Until now, liver transplantation is known as the only effective treatment for end …

Highlights•Engineering liver tissue addresses the shortage of donor organs for
transplantation.•Survival of liver constructs largely depends on efficiency of nutrient delivery …

The process of tissue regeneration requires the utilization of a scaffold, which serves as a
structural framework facilitating cellular adhesion, proliferation, and migration within a …

End‐stage hepatic failure is a potentially life‐threatening condition for which orthotopic liver
transplantation (OLT) is the only effective treatment. However, a shortage of available donor …

Decellularized human livers are considered the perfect extracellular matrix (ECM) surrogate
because both three‐dimensional architecture and biological features of the hepatic …